The Drug Resistant Tuberculosis Treatment Market is there to witness remarkable growth in the forecast period. The existing scenario implies the consumerization of healthcare. In other words, technology is relieving the hospital staff from providing an appropriate level of the care needed, that too, in a better way. Data-driven diagnosis has seen the light of the day in wake of habits and...

The global tuberculosis treatment market size was valued at USD 1.7 billion in 2021, registering at a CAGR of 6.1% from 2022 to 2028. Around a third of the world's population has latent TB; persons infected with mycobacterium infection have a 10% chance of getting tuberculosis; although, people with impaired immunity, such as HIV, diabetes, or cigarette addiction, have a greater chance of...